There is a ceremonial program with the participation of performersThe opening ceremony will be attended by Russian Deputy Prime Minister Tatyana Golikova, Federation Council Deputy Speaker Inna Svyatenko, State Duma Deputy Chairman Anna Kuznetsova, and Russian Minister of Health Mikhail Murashko.

The opening ceremony will be attended by young doctors, volunteers, artists and creative teams. In addition, the singer and Honoured Artist of Russia Pelageya and Olesya Kazachenko, a finalist from the show ‘The Voice. Children – 7’ and the show ballet ‘Todes’, will put on a special performance for the Congress participants.

One of the key indicators of Russia’s competitiveness is the extent of the development of its innovation and healthcare sectors. The National Security Strategy envisages the introduction of incentives by the government, the encouragement of private investment in innovative activities, and the accelerated introduction of their results to ensure the sustainable growth of the Russian economy. Russia has significant potential in terms of fundamental and applied research, an extensive system of scientific and educational centres, and advantages in a number of technologies. One of the tasks that is crucial to achieving the country’s goals of scientific and technological development is the creation of instruments to protect intellectual property and the expanded enforcement of patent legislation in order to get Russian businesses more interested in developing innovative activities. The development and introduction of new medical technologies and medicines is also pivotal to Russia’s healthcare strategy, including the creation of centralized digital platforms to diagnose diseases using artificial intelligence, the introduction of modern molecular genetic methods to forecast, diagnose, and monitor the progression of diseases, personalized pharmacotherapy methods, as well as numerous other existing and emerging technologies of the future. The strategy of supporting innovative developments has also been crucial to China’s success in recent decades in transforming the economy from a global producer of knowledge-intensive technological goods to a developer and pioneer in multiple fields of science. Some of the key features of the approach taken by Chinese innovative developers include their focus on the applied use of new technologies, the broad mobility and speed of decision-making, significant and diversified government support for innovators, as well as a focus on introducing new technologies equally in the local and foreign markets. What measures are most effective and essential to support the development and introduction of innovations? What regulatory conditions are needed to create the most conducive innovation ecosystem? What barriers to innovation have been encountered and still need to be addressed? How can innovation in healthcare be accelerated? What is the best way to gain international recognition in the context of intercountry competition for human capital, sales markets, and scientific leadership?

During the session, well-known Russian scientists and developers will share breakthrough achievements in the field of genetics, in the treatment of autoimmune and oncological diseases, as well as the development of vaccines and immunobiological drugs. The participants will discuss how innovations in the healthcare sector are becoming a key factor in ensuring a high-tech and personalized approach to patients, how these changes can be harmoniously integrated into the structure of the modern medical system, and what are the prospects for further technological development of Russian healthcare.

The functionality and role of nurses in terms of properly caring for patients has expanded in response to the progressive development of medical science and the introduction of innovative technologies into the healthcare system. At present, a pilot project is being successfully implemented to transfer certain functions of doctors to nurses for conducting medical examinations among the public, preventing non-communicable diseases, and promoting a healthy lifestyle. However, in order to effectively transform nursing activities, it is crucial to develop professional associations and non-formal education, establish youth councils among specialists with secondary medical educations, and create a talent pool of nursing service managers, given the shortage and high workload of nurses, the need for greater public recognition, and the insufficient use of modern technologies. What steps to optimize nursing activities will enhance the prestige of the profession and create the necessary conditions for the professional development of medical personnel? What is the best way to attract and retain highly qualified specialists at the local level? How does managing nursing activities affect the national healthcare system?

Drugs obtained from blood plasma are considered vital and essential medicines. More than a million patients in Russia need them every year. At present, the domestic market for blood products is directly dependent on imports. Given the lack of domestic production facilities and the constant need to make purchases abroad, the health of Russia’s citizens and, consequently, its national security is dependent on external economic conditions. Amidst the current global challenges, expanding and improving the production of medicines derived from blood plasma is a top priority for Russia’s development. In order to eliminate the domestic healthcare industry’s dependence on imported medicines and strengthen national security, Russia needs to achieve self-sufficiency in the production of basic blood products by expanding the presence of Russian medicines derived from blood plasma on the domestic pharmaceutical market, create modern industrial production facilities for medicines derived from blood plasma, and increase the amount of blood plasma purchases in order to create a stable supply of raw materials for drug production by modernizing plasma centres and building technological facilities for plasma fractionation. How can we effectively increase the donation of blood and its components at the federal and regional levels? What alternative methods of blood-saving technologies exist? What are the key focuses of Russia’s state policy for increasing purchases of blood plasma for drug production? What support measures will facilitate the regions’ involvement in the project to build plasma centres? How can we accelerate the expansion of domestic drugs derived from blood plasma on the Russian market?